Entry |
|
Name |
Elinogrel (USAN/INN) |
Formula |
C20H15ClFN5O5S2
|
Exact mass |
523.0187
|
Mol weight |
523.95
|
Structure |
|
Simcomp |
|
Class |
Blood modifier agent
DG01809 P2Y12 receptor antagonist
|
Remark |
|
Efficacy |
Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist |
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01809 P2Y12 receptor antagonist
DG01295 Elinogrel
D09607 Elinogrel
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Purine / pyrimidine
P2RY12
D09607 Elinogrel (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01809 P2Y12 receptor antagonist
DG01295 Elinogrel
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8y C 10.1500 -29.5400
2 C8y C 10.1500 -30.9400
3 C8x C 11.3400 -31.6400
4 C8y C 12.6000 -30.9400
5 C8y C 12.6000 -29.5400
6 C8x C 11.3400 -28.8400
7 N4x N 13.7900 -31.6400
8 C8y C 14.9800 -30.9400
9 N4y N 14.9800 -29.5400
10 C8y C 13.7900 -28.8400
11 C8y C 16.1700 -28.8400
12 O5x O 13.7900 -27.4400
13 O5x O 16.1700 -31.6400
14 X F 8.9600 -28.8400
15 N1b N 8.9600 -31.6400
16 C1a C 7.7700 -30.9400
17 C8x C 17.3600 -29.5400
18 C8x C 18.6200 -28.8400
19 C8y C 18.6200 -27.4400
20 C8x C 17.4300 -26.7400
21 C8x C 16.1700 -27.4400
22 N1b N 19.8100 -26.7400
23 C5a C 21.0000 -27.4400
24 N1b N 22.1900 -26.7400
25 O5a O 21.0000 -28.8400
26 S4a S 23.3800 -27.4400
27 C8y C 24.5700 -26.7400
28 C8x C 26.3900 -25.4100
29 C8x C 24.9900 -25.4100
30 S2x S 25.6900 -27.5800
31 C8y C 26.8100 -26.7400
32 X Cl 28.0000 -27.4400
33 O3c O 22.6800 -28.8624
34 O3c O 24.0800 -28.8624
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 10 12 2
14 8 13 2
15 1 14 1
16 2 15 1
17 15 16 1
18 11 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 11 21 2
24 19 22 1
25 22 23 1
26 23 24 1
27 23 25 2
28 24 26 1
29 26 27 1
30 28 29 1
31 29 27 2
32 27 30 1
33 30 31 1
34 28 31 2
35 31 32 1
36 26 33 2
37 26 34 2
|